Last updated on January 2018

A Phase 1 Trial to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of PC-6500 (Griffithsin [GRFT] in a Carrageenan Gel) in Healthy Women

Brief description of study

We are looking for healthy, HIV negative women using hormonal birth control (either the pill or patch) to participate in a study of an experimental vaginal gel. The purpose of the study is to see if the gel is safe  to be used in women. The study is a total of 4 visits, including screening. Participation involves, blood draws, STI testing, pregnancy testing, HIV testing, pelvic exams, and EKG. Compensation is provided.

Clinical Study Identifier: TX154680

Contact Investigators or Research Sites near you

Start Over

Arisa Kapedani, Study Coordinator

Einstein-Montefiore Institute for Clinical and Translational Research
Bronx, NY USA
  Connect »